All Stories

  1. Liver resection volume-dependent pancreatic strain following living donor hepatectomy
  2. Microanatomical organization of hepatic venous lymphatic system in humans
  3. Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
  4. Differential diagnoses of gallbladder tumors using CT‐based deep learning
  5. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma
  6. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
  7. Short‐term outcomes of robotic‐assisted surgery following neoadjuvant chemotherapy for lower rectal cancer
  8. ASO Author Reflections: Reconsidering the Treatment Strategy for Resectable Pancreatic Cancer Using a Biomarker-Based Scoring System for Prediction of Early Recurrence
  9. ASO Visual Abstract: Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
  10. Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree
  11. Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreatic cancer
  12. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
  13. Intraoperative Allogeneic Red Blood Cell Transfusion Negatively Influences Prognosis After Radical Surgery for Pancreatic Cancer
  14. Roles of the nervous system in pancreatic cancer
  15. Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type
  16. A case report of mucinous adenocarcinoma derived from intra-ampullary papillary-tubular neoplasm with a malignant course
  17. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
  18. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation
  19. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis
  20. Pathological impact on the stroma after preoperative chemotherapy with nab-paclitaxel and gemcitabine for pancreatic cancer
  21. Impact of Smoking Cessation in Donor Candidates for Living Donor Liver Transplantation
  22. Long-term Changes in Spleen Volume After Living Donor Liver Transplantation in Pediatric Recipients
  23. Castleman’s Lymphoma with Primary Occurrence in the Right Diaphragm
  24. Effect of sarcopenia on the outcomes after pancreaticoduodenectomy for distal cholangiocarcinoma
  25. Smoking cessation contributes to weight gain in patients with hepatobiliopancreatic malignancy
  26. Impact of the histological phenotype of extrahepatic bile duct carcinoma
  27. Microanatomical profiles on the lymphatic system in the human ampulla of Vater (immunohistochemistry and scanning electron microscopy)
  28. Living-Donor Liver Transplantation With the Use of a Left-Lobe Graft From a Donor With Anomalous Biliary Anatomy in Which B4 Joins the Right Anterior Sectional Duct: A Case Report
  29. Effect of age on the development of chemotherapy‑associated liver injury in colorectal cancer liver metastasis
  30. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer
  31. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
  32. Perihilar Cholangiocarcinoma with Constitutional Indocyanine Green Defect Treated by Right Hemihepatectomy Extending to Segment 1
  33. Living donor liver transplantation in a pediatric patient with preexisting yolk sac tumor
  34. A study of non-alcoholic fatty liver disease after pancreatic surgery
  35. Preoperative assessment of early recurrence of pancreatic ductal denocarcinoma
  36. Locally Advanced Gallbladder Cancer Treated with Chemotherapy and Subsequent Curative Resection
  37. Impact of the serum ferritin concentration in liver transplantation
  38. Examinations of ascites from prophylactic drains can predict intra-abdominal infections after living donor liver transplantation
  39. Successful rescue of disseminated varicella infection with multiple organ failure in a pediatric living donor liver transplant recipient: a case report and literature review
  40. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma
  41. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: The experience of a single center
  42. Perioperative Blood Transfusion as a Poor Prognostic Factor After Aggressive Surgical Resection for Hilar Cholangiocarcinoma
  43. Selection of living donor liver grafts for patients weighing 6kg or less
  44. Can Serum Ferritin Concentration Predict Mortality in Pediatric Patients After Liver Transplantation.
  45. How to Use Rituximab in ABO-Incompatible Pediatric Living Donor Liver Transplantation: A Single Center Experience.
  46. The Long-Term Prognosis and Treatments of Biliary Complications After Living Donor Liver Transplantation.
  47. Iron Overload After Pediatric Liver Transplantation: A Case Report
  48. Successful Treatment of Severe Anastomotic Stricture of a Choledochojejunostomy After Living Donor Liver Transplantation With Transhepatic Cholangioscopy-Guided Balloon Dilatation
  49. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia
  50. Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation
  51. Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation
  52. Risk factors and treatments for hepatic arterial complications in pediatric living donor liver transplantation
  53. Decreased portal vein flow during Kawasaki disease in a liver transplant patient
  54. Evaluation of the Usefulness of the Indocyanine Green Clearance Test for Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis
  55. Robot-assisted pancreatectomy for distal pancreatic tumor
  56. Effect of Repeat Kasai Hepatic Portoenterostomy on Pediatric Live-Donor Liver Graft for Biliary Atresia
  57. Impact of endotoxin measured by an endotoxin activity assay during liver transplantation
  58. Development of nonalcoholic fatty liver disease after pancreaticoduodenectomy
  59. A Comparison of Open Surgery and Endovascular Intervention for Hepatic Artery Complications After Pediatric Liver Transplantation
  60. Impact of localized ascites after pediatric living donor liver transplantation: report of three cases
  61. The efficacy of measurement of the serum beta-d glucan in the patients with biliary atresia
  62. Liver graft volumetric changes after living donor liver transplantation with segment 2 graft for small infants
  63. Use of 3-Dimensional Computed Hepatic Venous Visualization for Graft Outflow Venoplasty in Adult Left Living-Donor Liver Transplant
  64. Impact of Posttransplant Portosystemic Shunts on Liver Transplantation
  65. Role of Apheresis and Dialysis in Pediatric Living Donor Liver Transplantation: A Single Center Retrospective Study
  66. Prediction of Acute Cellular Rejection by Peripheral Blood Eosinophilia in Pediatric Living Donor Liver Transplantation
  67. Transumbilical portal venous catheterization: a useful adjunct in left lobe living donor liver transplantation
  68. Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency
  69. Co-occurrence of Nonanastomotic Biliary Stricture and Acute Cellular Rejection in Liver Transplant
  70. Varicella Zoster Virus Disease After Pediatric Living Donor Liver Transplantation: Is It Serious?
  71. Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Associated With Potential Antibody-Mediated Rejection After Pediatric Living Donor Liver Transplantation: A Case Report
  72. Liver transplantation for a pediatric patient with hemophilia B
  73. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency
  74. The role of operative intervention in management of congenital extrahepatic portosystemic shunt
  75. Living Donor Liver Transplantation in Children With Cholestatic Liver Disease: A Single-Center Experience
  76. Hepatocellular Telomere Length in Biliary Atresia Measured by Q‐FISH
  77. Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation
  78. Hepatic Arterial Buffer Response after Pediatric Living Donor Liver Transplantation: Report of a Case
  79. Pediatric liver retransplantation from living donors can be considered as a therapeutic option for patients with irreversible living donor graft failure
  80. Endovascular interventions for hepatic artery complications immediately after pediatric liver transplantation
  81. Impact of hepatic clearance of endotoxin using endotoxin activity assay
  82. Living donor liver transplantation for ornithine transcarbamylase deficiency
  83. Pediatric living donor liver transplantation for biliary atresia with hepatopulmonary syndrome: the gift of a second wind
  84. Indication of liver transplantation for jaundice-free biliary atresia with portal hypertension
  85. Liver allograft with hemangioma in pediatric living donor liver transplantation
  86. Interventional radiology for hepatic artery complications soon after living donor liver transplantation in a neonate
  87. Hepatic artery reconstruction with the jejunal artery of the Roux‐en‐Y limb in pediatric living donor liver re‐transplantation
  88. Living-Donor Liver Transplantation in 126 Patients with Biliary Atresia: Single-Center Experience
  89. Management of Intra-Abdominal Drain After Living Donor Liver Transplantation
  90. Living Donor Liver Transplantation for Neonates Using Segment 2 Monosubsegment Graft
  91. Bowel perforation after pediatric living donor liver transplantation
  92. Double-balloon enteroscopy for bilioenteric anastomotic stricture after pediatric living donor liver transplantation
  93. Strategy to prevent recurrent portal vein stenosis following interventional radiology in pediatric liver transplantation
  94. An efficacy of surgical treatment for congenital extrahepatic portosystemic shunt: Report of two cases
  95. Living Donor Liver Transplantation for Congenital Absence of the Portal Vein